Loading…
Dogwood Therapeutics, Inc. is projected to rise to $1.79 by 2027, a +19% move from its current price of $1.50. DWTX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/25/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 26 | $1.45 | $1.50 | $1.56 | +0.04% |
| Jul 27 | $1.42 | $1.50 | $1.58 | +0.09% |
| Jul 28 | $1.41 | $1.50 | $1.60 | +0.13% |
| Jul 29 | $1.40 | $1.50 | $1.62 | +0.17% |
| Jul 30 | $1.38 | $1.50 | $1.63 | +0.22% |
| Jul 31 | $1.37 | $1.50 | $1.65 | +0.26% |
| Aug 1 | $1.36 | $1.50 | $1.66 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.36 | $1.50 | $1.66 | +0.30% |
| Week 2 | $1.31 | $1.51 | $1.73 | +0.60% |
| Week 3 | $1.28 | $1.51 | $1.79 | +0.91% |
| Week 4 | $1.25 | $1.52 | $1.85 | +1.21% |
| Week 5 | $1.22 | $1.52 | $1.90 | +1.52% |
| Week 6 | $1.20 | $1.53 | $1.94 | +1.82% |
| Week 7 | $1.18 | $1.53 | $1.99 | +2.13% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Dogwood Therapeutics, Inc. is a development-stage biotechnology company focused on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain; and IMC-2, a combination of valacyclovir and celecoxib intended to synergistically suppress herpesvirus activation; and Serpin Peptide 16 that is in early Phase 1 development to reduce neuropathy secondary to treat chemotherapeutic agents that are neurotoxic.
The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is based in Alpharetta, Georgia.
Dogwood Therapeutics, Inc. trades at $1.54. Its market capitalization is $51.79M and it is ranked 4437. The price outlook is reflected in the year-by-year forecast, which shows a flat start in 2026 with an average price of $1.54 and a path to higher values by mid-century, including a 2040 average of $3.22 and a 2050 average of $4.34.
The forecast also lists a 2050 maximum of $9.09, underscoring potential upside despite a low current price.
A major floor 23.1% below — a decisive break under it would weaken the trend.
The nearest floor, 8.7% below — buyers have tended to step in here.
The nearest ceiling, 18.7% above — a clean break opens room to run.
A major ceiling 114.7% above — clearing it would confirm fresh momentum.
Key DWTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DWTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.43 | Buy | $1.46 | Buy |
| MA 10 | $1.42 | Buy | $1.44 | Buy |
| MA 20 | $1.47 | Buy | $1.46 | Buy |
| MA 50 | $1.58 | Sell | $1.59 | Sell |
| MA 100 | $1.86 | Sell | $2.00 | Sell |
| MA 200 | $3.31 | Sell | $2.87 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.43 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 62.17 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 6.94 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.46 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 63.72 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 1.46 | Buy |
| ADX (14) | 13.54 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 50, and the 50-day simple moving average is $1.58 while the 200-day simple moving average is $3.31. There is support at $1.37 and resistance at $1.78. The 30-day range runs from $1.21 to $1.97.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.34 | $1.50 | $2.08 | 0% | Neutral | |
| $1.38 | $1.79 | $2.48 | +19% | Neutral | |
| $1.35 | $1.82 | $2.65 | +22% | Bullish | |
| $1.31 | $1.82 | $2.75 | +22% | Bullish | |
| $1.07 | $1.53 | $2.39 | +2% | Neutral | |
| $1.12 | $1.65 | $2.64 | +10% | Neutral | |
| $1.28 | $1.94 | $3.17 | +29% | Bullish | |
| $1.31 | $2.03 | $3.40 | +36% | Bullish | |
| $1.44 | $2.28 | $3.89 | +52% | Bullish | |
| $1.40 | $2.27 | $3.95 | +51% | Bullish | |
| $1.74 | $3.13 | $5.88 | +109% | Bullish | |
| $1.96 | $4.24 | $8.87 | +182% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.34 | $1.50 | $1.80 | +0.00% |
| August 2026 | $1.34 | $1.59 | $1.94 | +6.13% |
| September 2026 | $1.30 | $1.56 | $1.94 | -2.01% |
| October 2026 | $1.26 | $1.52 | $1.91 | -2.62% |
| November 2026 | $1.30 | $1.58 | $2.01 | +3.95% |
| December 2026 | $1.32 | $1.62 | $2.08 | +2.73% |
Click any year to see its month-by-month DWTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DWTX is projected to trade between $1.34 and $2.08, averaging $1.50 — a potential gain of 0% from today's $1.50. Price action looks broadly range-bound.
Dogwood Therapeutics, Inc.'s 2027 outlook centres on $1.79, within a $1.38 to $2.48 range. That is up +19% on the projected 2026 average. That marks a +19% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, DWTX could reach as high as $2.65, with a base case around $1.82 and support toward $1.35 — roughly +22% from $1.50. Momentum favours further upside here.
Expect DWTX to range from $1.31 to $2.75 through 2029. The $1.82 average target implies a +22% move from current prices. That is up 0% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The DWTX price prediction for 2030 points to an average of $1.53 (low $1.07, high $2.39) — a potential gain of +2% on today's $1.50. Price action looks broadly range-bound.
In 2031, DWTX is projected to trade between $1.12 and $2.64, averaging $1.65 — a potential gain of +10% from today's $1.50. That is up +7% on the projected 2030 average. A consolidation phase looks the most probable path here.
Dogwood Therapeutics, Inc.'s 2032 outlook centres on $1.94, within a $1.28 to $3.17 range. That is up +18% on the projected 2031 average. That marks a +29% change versus current levels. Momentum favours further upside here.
By 2033, DWTX could reach as high as $3.40, with a base case around $2.03 and support toward $1.31 — roughly +36% from $1.50. Buyers look set to stay in control over this stretch.
Expect DWTX to range from $1.44 to $3.89 through 2034. The $2.28 average target implies a +52% move from current prices. That is up +12% on the projected 2033 average. Momentum favours further upside here.
The DWTX price prediction for 2035 points to an average of $2.27 (low $1.40, high $3.95) — a potential gain of +51% on today's $1.50. Buyers look set to stay in control over this stretch.
In 2040, DWTX is projected to trade between $1.74 and $5.88, averaging $3.13 — a potential gain of +109% from today's $1.50. That is up +38% on the projected 2035 average. Momentum favours further upside here.
Dogwood Therapeutics, Inc.'s 2050 outlook centres on $4.24, within a $1.96 to $8.87 range. That is up +35% on the projected 2040 average. That marks a +182% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in DWTX today (≈ 666.666667 DWTX) could be worth
$2,823.81
+$1,823.81 (+182%) by 2050 · US Dollar
Based on the average projected DWTX price of $4.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DWTXwould be worth at today's price.
$1,000 invested in DWTX on Jul 23, 2025 (≈ 207.468872 DWTX) would be worth
$311.2
-$688.8 (-68.9%) today · 0.31× · US Dollar
Based on a DWTX entry price of $4.82 vs. today's $1.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.37 | $1,094.89 | +9.5% |
| 1 month ago | $1.55 | $967.74 | -3.2% |
| 3 months ago | $1.38 | $1,086.96 | +8.7% |
| 6 months ago | $2.98 | $503.36 | -49.7% |
| 1 year ago | $4.82 | $311.2 | -68.9% |
| All time (5.0y) ago | $142 | $10.56 | -98.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DWTX forecast.
Our base-case forecast reaches $3.00 around 2040.
Implied market cap at $3.00: $100.89M
The multi-year forecast shows mixed momentum in the near term with stronger upside later. In 2027 the average price is $1.84 with ROI of 19.4%; 2028 shows an average of $1.87 with ROI of 21.6%; 2029 has an average of $1.87 with ROI of 21.4%; 2030 sits at an average of $1.58 with ROI of 2.3%. The forecast then projects 2032 at an average of $1.99 (ROI 29.1%), 2033 at $2.08 (ROI 35.4%), 2034 at $2.34 (ROI 52%), and 2035 at $2.33 (ROI 51.3%).
Longer term, 2040 shows an average of $3.22 (ROI 108.9%) and 2050 shows an average of $4.34 (ROI 182.1%), with bullish sentiment in those later years.
Tap a question to reveal the answer.
2030 average price is $1.58 with min $1.10 and max $2.45; ROI 2.3%; sentiment NEUTRAL.
Forecasts show a mix of NEUTRAL and BULLISH years, with 2026 average $1.54 (ROI 0%), 2027 average $1.84 (ROI 19.4%), 2040 average $3.22 (ROI 108.9%), and 2050 average $4.34 (ROI 182.1%), indicating potential upside but with volatility.
Yes, the modeled upside includes 2040 max $6.04 and 2050 max $9.09, while 2050 average is $4.34, suggesting that $5 could be reached within the forecasted range.
Current price $1.54; Market cap $51.79M.
30-day range is from $1.21 to $1.97; annualized volatility 70%.
Dogwood Therapeutics, Inc. Community Discussion
0Share your Dogwood Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.